QUICK MARKET SUMMARY: CONSUMER: 🔸 Calavo Growers ( $CVGW): $25M buyback. 🔸 Tesla ( $TSLA): Upgraded to Overweight at Cantor, PT $425. 🔸 Waldencast ( $WALD): Q4 EBITDA missed slightly; FY guidance below estimates. ENERGY/INDUSTRIALS/MATERIALS: 🔸 Kratos ( $KTOS): Building $50M hypersonic facility in Indiana. 🔸 Mosaic ( $MOS): Upgraded to Overweight at Barclays, PT $33. FINANCIALS: 🔸 Goldman Sachs ( $GS), Carlyle (CG), Jefferies (JEF): Downgraded at Oppenheimer. 🔸 Morgan Stanley ( $MS): Plans 2,000 job cuts. 🔸 StoneCo ( $STNE): Strong Q4 EPS and revenue beat; upbeat 2025 profit outlook. HEALTHCARE: 🔸 Absci ( $ABSI): Missed Q4; cash runway into 1H’27. 🔸 Gilead ( $GILD): Shares drop as CDC HIV division review raises concerns. 🔸 HealthEquity ( $HQY): Slight Q4 miss; FY guidance in line. 🔸 Inovio ( $INO): Missed Q4; cash runway into Q1’26. 🔸 OmniAb ( $OABI): Revenue beat; stronger FY outlook. 🔸 Pfizer ( $PFE): Raised $3.3B from Haleon stake sale. 🔸 Purdue Pharma: Filed new bankruptcy plan for opioid settlement. 🔸 Trevi ( $TRVI): Positive trial data; strong cash position. TECH/MEDIA/TELECOM: 🔸 Asana ( $ASAN): Filed mixed securities shelf. 🔸 Foxconn: Expects server revenue to surpass iPhones in 2 years. 🔸 FuboTV ( $FUBO): Partnered with Texas Rangers for streaming broadcasts. 🔸 HPE & NVIDIA ( $NVDA): Launched new AI solutions. 🔸 Oracle ( $ORCL) & NVIDIA (NVDA): Announced major AI integration. 🔸 Synopsys ( $SNPS) & NVIDIA: Teaming up to speed chip design. 🔸 Teradyne Robotics ( $TER): Showcasing AI robotics at NVIDIA GTC 2025.

MORNING BID 🔸 QXO ( $QXO) is in talks to buy Beacon Roofing Supply (BECN) for $11B ($124.35/share in cash). 🔸 Uber ( $UBER) & Lyft ( $LYFT) dominate North American ride-hailing, but Bolt aims to challenge them, per The Information. 🔸 Xpeng ( $XPEV) plans to mass-produce its modular flying car by 2026, said Chairman He Xiaopeng. 🔸 Yum China ( $YUM) appointed Adrian Ding as CFO, removing his interim title after a search following Andy Yeung’s resignation. 🔸 Franco-Nevada ( $FNV) Q4 adj. EPS $0.95 (est. $0.89), revenue $321M (+6% y/y, est. $304.44M); expects 2025 revenue to rise 25%+ with gold at $2,800/oz. Upgrades: 🔸 Grainger ( $GWW), Fastenal (FAST) → Outperform (from Market Perform) at William Blair. 🔸 Knight-Swift ( $KNX) → Neutral (from Sell) at Citigroup. Downgrade: 🔸 Sherwin-Williams ( $SHW) → Hold (from Buy) at Jefferies. 🔸 Beam Therapeutics ( $BEAM) prices 16.2M shares at $28.48 each. 🔸 DexCom ( $DXCM) gets FDA warning after inspections but sees no material impact on FY25 revenue. 🔸 Nordisk ( $NVO) reports REDEFINE 2 trial met its primary endpoint, showing significant weight loss with CagriSema in 1,206 patients over 68 weeks. 🔸 Trevi ( $TRVI) Phase 2a RIVER trial: Haduvio reduced 24-hour cough frequency by 67% (57% placebo-adjusted, p<0.0001). 🔸 Cognizant ( $CTSH) shares rose as Mantle Ridge built a $1B+ stake, seeing them as undervalued (WSJ). Upgrades: 🔸 DocuSign ( $DOCU) → Neutral (from Underweight) at JPMorgan. Deals: 🔸 NVent ( $NVT) to buy Avail’s electrical products for $975M, expects EPS boost in year one. 🔸 Perion ( $PERI) expands buyback program to $125M. 🔸 Taiwan Semi ( $TSM) Feb revenue NT$260.01B (+43% y/y, -11% m/m); Jan-Feb total NT$553.30B (+39% y/y).